Surgical Science Sweden

Surgical Science Sweden ROCE

The Return on Capital Employed (ROCE) of Surgical Science Sweden (SUS.ST) as of Nov 3, 2026 is 2.55 %. In the previous year, Return on Capital Employed (ROCE) was 2.99 % — a change of -14.68% (lower).

ROCE

2.55 %

YoY

-14.68%

Last updated:

In 2025, Surgical Science Sweden's return on capital employed (ROCE) was 2.55 %, a -14.68% increase from the 2.99 % ROCE in the previous year.

The Surgical Science Sweden ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
-5.13 SEK
Jan 1, 2019
3.78 SEK
Jan 1, 2020
4.68 SEK
Jan 1, 2021
2.48 SEK
Jan 1, 2022
3.84 SEK
Jan 1, 2023
4.35 SEK
Jan 1, 2024
2.99 SEK
Jan 1, 2025
2.55 SEK
The Surgical Science Sweden ROCE history
YEARROCEYoY
2.55 %-14.68%
2.99 %-31.34%
4.35 %+13.46%
3.84 %+54.98%
2.48 %-47.07%
4.68 %+23.79%
3.78 %-173.71%
-5.13 %+0.36%
-5.11 %+472.04%
-0.89 %-109.72%
9.18 %-217.39%
-7.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Surgical Science Sweden Stock analysis

What does Surgical Science Sweden do? Surgical Science Sweden AB is a Swedish company specializing in the development and manufacturing of medical simulators for training professionals in the medical industry. The company was founded in 1999 by a team of doctors, engineers, and scientists and is headquartered in Gothenburg. Since then, the company has constantly expanded and now has several branches around the world, including in the USA, Germany, and Hong Kong. Due to its innovative products and high-quality standards, the company is globally recognized and has received numerous awards. Surgical Science Sweden AB offers a wide range of simulators for various medical disciplines, including surgery, anesthesia, obstetrics, and pediatrics. They offer both hardware and software-based solutions that allow trainees to practice complex procedures and interventions in a safe environment. The company's business model is based on the belief that simulation is crucial for the training of medical professionals to ensure the highest quality and safety for patients. By simulating realistic situations, trainees can gain valuable experience before working in the real practice. Surgical Science Sweden AB has a range of products targeting various areas of medical education. One of their most well-known simulators is the LaparoSculptor, which was specifically developed for training in minimally invasive surgery. The simulator can perform various procedures such as gallbladder and hernia operations, offering both physical and virtual options. Another product is the ObstetricSim, a simulator for obstetric training. The simulator fully simulates the conditions of a normal birth, including the stages of labor and delivery. It also includes rare complications such as shoulder dystocia and umbilical cord prolapse. Surgical Science Sweden AB has also developed simulators focusing on the training of anesthesiologists. The simulator in this area is the ANTS (Anesthesia Simulator), which trains trainees in the proper use of anesthetics, patient observation, and managing emergencies during anesthesia issues. In addition to developing hardware and software solutions, the company also focuses on continuous improvement and development of its products. Surgical Science Sweden AB works closely with leading medical specialists to ensure that the simulator meets the latest requirements and best practices. The company is also willing to rent or sell the simulators and its expertise to medical institutions, providing a broader audience with the opportunity to benefit from the technology. In conclusion, Surgical Science Sweden AB makes a significant contribution to the training of medical professionals and thereby contributes to improving patient health worldwide with its innovative and high-quality simulators. By combining the latest technology, industry expertise, and a constant focus on customer needs, the company continuously strives for excellence and innovation. Surgical Science Sweden is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Surgical Science Sweden's Return on Capital Employed (ROCE)

Surgical Science Sweden's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Surgical Science Sweden's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Surgical Science Sweden's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Surgical Science Sweden’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Surgical Science Sweden stock

Return on Capital Employed (ROCE) of Surgical Science Sweden is 2.55 % in 2025.

Return on Capital Employed (ROCE) of Surgical Science Sweden changed from 2.99 % to 2.55 %, representing a -14.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Surgical Science Sweden since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Surgical Science Sweden with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Surgical Science Sweden

All Key Metrics — Surgical Science Sweden